ArticlePediatric blood & cancer2021

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).

David Van Mater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.